Pfizer-BioNTech released data claiming their pediatric COVID-19 vaccine for children six-months- to five-years-old is effective and “demonstrates strong immune response, high efficacy and favorable safety” following a third dose. Once submitted, approval could happen very quickly.

For more information, click here.